These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15958821)

  • 21. [Anemia in chronic renal insufficiency and chronic failure].
    Zahálková J
    Vnitr Lek; 2003 May; 49(5):379-82. PubMed ID: 12908172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
    Singh AK; Hertello P
    Nephrol Nurs J; 2005; 32(2):199-206; quiz 207-8. PubMed ID: 15889804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does early anemia correction prevent complications of chronic renal failure?
    Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
    Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
    Portolés J; López-Gómez JM; Aljama P
    Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia and cardiovascular risk in the patient with kidney disease.
    Fishbane S
    Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CREATE trial--building the evidence.
    Eckardt KU;
    Nephrol Dial Transplant; 2001; 16 Suppl 2():16-8. PubMed ID: 11369844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia and heart failure in chronic kidney disease.
    Locatelli F; Pozzoni P; Del Vecchio L
    Semin Nephrol; 2005 Nov; 25(6):392-6. PubMed ID: 16298261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anemia in renal insufficiency.
    Santoro A
    Rev Clin Exp Hematol; 2002; Suppl 1():12-20. PubMed ID: 12735211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease?
    Paoletti E; Cannella G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S74-7. PubMed ID: 16565252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.
    Thorp ML; Johnson ES; Yang X; Petrik AF; Platt R; Smith DH
    Nephrology (Carlton); 2009 Apr; 14(2):240-6. PubMed ID: 19207866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease.
    McClellan WM; Jurkovitz C; Abramson J
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():58-65. PubMed ID: 16281960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular complications in patients with chronic renal insufficiency and chronic kidney failure].
    Tesar V
    Vnitr Lek; 2003 May; 49(5):383-7. PubMed ID: 12908173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating anemia at different stages of renal disease.
    Locatelli F; Del Vecchio L; Pozzoni P
    J Nephrol; 2007; 20 Suppl 12():S33-8. PubMed ID: 18050140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blockade in chronic dialysis patients.
    Furgeson SB; Chonchol M
    Semin Dial; 2008; 21(1):43-8. PubMed ID: 18251957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is early treatment of anaemia with epoetin-alpha beneficial to pre-dialysis chronic kidney disease patients? Results of a multicentre, open-label, prospective, randomized, comparative group trial.
    Macdougall IC; Temple RM; Kwan JT
    Nephrol Dial Transplant; 2007 Mar; 22(3):784-93. PubMed ID: 16968726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
    Spinowitz BS; Pratt RD;
    Curr Med Res Opin; 2006 Dec; 22(12):2507-13. PubMed ID: 17166333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.